Dabble.addView({"_class": "View", "id": "d8901093-e90e-40a9-b7db-39785a496e6e", "name": "Published FDC stories", "fields": [64, 510, 6687, 46288, 43232, 87904], "entries": [
{"_name": "3SBio CEO Jing Lou On Building An Integrated Biopharma Company In China: An Interview With PharmAsia News", "_id": 831509, "_link": "http://tromblyltd.dabbledb.com/dabble/reports?view=793332&entry=831509",  "values": ["3SBio CEO Jing Lou On Building An Integrated Biopharma Company In China: An Interview With PharmAsia News", {"_id": 497687, "_name": "Ying Huang" }, {"name": "April 28, 2008", "start": 1209312000, "end": 1209398399 }, "", "http://www.pharmasianews.com/fdcreports/story/viewStory.do?targetGUID={A8BDB677-7905-43DA-90DD-F817C3C5F245}", 1557]},
{"_name": "China’s State FDA To Implement Electronic Tracking Network To Improve Drug Safety", "_id": 827714, "_link": "http://tromblyltd.dabbledb.com/dabble/reports?view=793332&entry=827714",  "values": ["China’s State FDA To Implement Electronic Tracking Network To Improve Drug Safety", {"_id": 79435, "_name": "Dai Jialing" }, {"name": "April 19, 2008", "start": 1208534400, "end": 1208620799 }, "SHANGHAI - China's State SFDA will implement an electronic ID-based drug-tracking system this year, the drug watchdog announced at a monthly press conference April 8. ", "http://www.pharmasianews.com/fdcreports/story/viewStory.do?targetGUID={B659FA7D-6A41-49BE-9992-6D7B1E3E00F9}", 668]},
{"_name": "Shanghai ChemPartner CEO Michael Hui On Finding A Niche In China Amidst Increasing Foreign Competition: An Interview With PharmAsia News", "_id": 797291, "_link": "http://tromblyltd.dabbledb.com/dabble/reports?view=793332&entry=797291",  "values": ["Shanghai ChemPartner CEO Michael Hui On Finding A Niche In China Amidst Increasing Foreign Competition: An Interview With PharmAsia News", {"_id": 79435, "_name": "Dai Jialing" }, {"name": "April 14, 2008", "start": 1208102400, "end": 1208188799 }, "Shanghai ChemPartner was set up in 2003 at Shanghai's Zhangjiang Hi-Tech Park, and today it is one of the leading R&D outsourcing providers in China. PharmAsia News recently visited company headquarters to meet Michael Hui, CEO of ChemPartner - as well as sister company ChemExplorer, and their holding company ShangPharma - to discuss the company's recent deal with private equity investment firm TPG, as well as handling increased competition from foreign firms moving into China. \r\n", "http://www.pharmasianews.com/fdcreports/story/viewStory.do?targetAN=28080414004", 2785]},
{"_name": "Chinese Pharma Benda Reports 66 Percent Increase In Revenue For 2007", "_id": 794632, "_link": "http://tromblyltd.dabbledb.com/dabble/reports?view=793332&entry=794632",  "values": ["Chinese Pharma Benda Reports 66 Percent Increase In Revenue For 2007", {"_id": 497687, "_name": "Ying Huang" }, {"name": "April 10, 2008", "start": 1207756800, "end": 1207843199 }, "", "http://www.pharmasianews.com/fdcreports/story/viewStory.do?targetGUID={34D7575A-4FC7-4951-8E16-BD45CE688019}   ", 476]},
{"_name": "Sinovac’s Panflu Is First Chinese Avian Flu Vaccine Approved By SFDA", "_id": 794393, "_link": "http://tromblyltd.dabbledb.com/dabble/reports?view=793332&entry=794393",  "values": ["Sinovac’s Panflu Is First Chinese Avian Flu Vaccine Approved By SFDA", {"_id": 497687, "_name": "Ying Huang" }, {"name": "April 9, 2008", "start": 1207670400, "end": 1207756799 }, "", "http://www.pharmasianews.com/fdcreports/story/viewStory.do?targetGUID={157107A4-1999-417F-A412-A03DD593EA3F}", 612]},
{"_name": "China’s Ministry Of Health Investigates More Than 1,000 Bribery Cases In 2007", "_id": 781468, "_link": "http://tromblyltd.dabbledb.com/dabble/reports?view=793332&entry=781468",  "values": ["China’s Ministry Of Health Investigates More Than 1,000 Bribery Cases In 2007", {"_id": 79435, "_name": "Dai Jialing" }, {"name": "April 6, 2008", "start": 1207411200, "end": 1207497599 }, "- China's Ministry of Health uncovered 1,001 commercial bribery cases related to the purchase and distribution of drugs, medical equipment and medical services during 2007, the MOH announced March 21. \r\n\r\n", "http://www.pharmasianews.com/fdcreports/story/viewStory.do?targetGUID={CC7FD54D-464E-4873-9474-FC7908D12979}", 452]},
{"_name": "China’s Ministry Of Health Expands Immunization Program", "_id": 790610, "_link": "http://tromblyltd.dabbledb.com/dabble/reports?view=793332&entry=790610",  "values": ["China’s Ministry Of Health Expands Immunization Program", {"_id": 497687, "_name": "Ying Huang" }, {"name": "April 3, 2008", "start": 1207152000, "end": 1207238399 }, "", "http://www.pharmasianews.com/fdcreports/story/viewStory.do?targetGUID={425AA883-2880-4953-A278-9E031632D7CE}", 573]},
{"_name": "India’s Supplement Regulations Developing With Advantage For Industry", "_id": 698884, "_link": "http://tromblyltd.dabbledb.com/dabble/reports?view=793332&entry=698884",  "values": ["India’s Supplement Regulations Developing With Advantage For Industry", {"_id": 580020, "_name": "Mayur Pahilajani" }, {"name": "April 2, 2008", "start": 1207065600, "end": 1207151999 }, "India's development of regulatory and quality standards for nutraceutical products gives the industry an advantage it does not have in the U.S. because Indian government officials historically support the industry, market analyst and trade group executive Jon Benninger says. ", "www.tansheet.com", 889]},
{"_name": "Flagship Global Health And China Healthcare Ink Deal To Expand Insurance Services In China", "_id": 779769, "_link": "http://tromblyltd.dabbledb.com/dabble/reports?view=793332&entry=779769",  "values": ["Flagship Global Health And China Healthcare Ink Deal To Expand Insurance Services In China", {"_id": 497687, "_name": "Ying Huang" }, {"name": "April 2, 2008", "start": 1207065600, "end": 1207151999 }, "", "http://www.pharmasianews.com/fdcreports/story/viewStory.do?targetGUID={39E19936-CE72-49C6-8507-1B74B7009D61}&AuthToken=-792721706", 681]},
{"_name": "China's State FDA Gears Up For New Medical Device Recall Regulations", "_id": 772181, "_link": "http://tromblyltd.dabbledb.com/dabble/reports?view=793332&entry=772181",  "values": ["China's State FDA Gears Up For New Medical Device Recall Regulations", {"_id": 497687, "_name": "Ying Huang" }, {"name": "March 30, 2008", "start": 1206806400, "end": 1206892799 }, "", "http://www.pharmasianews.com/fdcreports/story/viewStory.do?targetGUID={4593C1F5-7C96-4E37-B19C-7B4634E17F38}", 763]},
{"_name": "Wyeth Builds Major New Facility In China", "_id": 753543, "_link": "http://tromblyltd.dabbledb.com/dabble/reports?view=793332&entry=753543",  "values": ["Wyeth Builds Major New Facility In China", {"_id": 497687, "_name": "Ying Huang" }, {"name": "March 24, 2008", "start": 1206288000, "end": 1206374399 }, "", "http://www.pharmasianews.com/fdcreports/story/viewStory.do?targetGUID={45E4B0AC-D981-4D77-8AF9-745623B6DE2A}", 517]},
{"_name": "Alnylam Makes Entry Into Chinese RNAi Market", "_id": 772563, "_link": "http://tromblyltd.dabbledb.com/dabble/reports?view=793332&entry=772563",  "values": ["Alnylam Makes Entry Into Chinese RNAi Market", {"_id": 79435, "_name": "Dai Jialing" }, {"name": "March 24, 2008", "start": 1206288000, "end": 1206374399 }, "", "http://www.pharmasianews.com/fdcreports/story/viewStory.do?targetGUID={563123D3-2EB0-4A64-A676-A24D63C37848}&AuthToken=2013720623", 221]},
{"_name": "China’s MOH-SFDA Merger: Analysts Weigh In", "_id": 738817, "_link": "http://tromblyltd.dabbledb.com/dabble/reports?view=793332&entry=738817",  "values": ["China’s MOH-SFDA Merger: Analysts Weigh In", {"_id": 497687, "_name": "Ying Huang" }, {"name": "March 20, 2008", "start": 1205942400, "end": 1206028799 }, "", "http://www.pharmasianews.com/fdcreports/story/viewStory.do?targetGUID={E15D1F15-612A-4AF5-A21E-59E942A2D90D}&CID_RESET_TOKEN=true&AuthToken=381250560", 869]},
{"_name": "Medical Insurance Plan Expected To Boost Size Of China Pharma Market", "_id": 721099, "_link": "http://tromblyltd.dabbledb.com/dabble/reports?view=793332&entry=721099",  "values": ["Medical Insurance Plan Expected To Boost Size Of China Pharma Market", {"_id": 79435, "_name": "Dai Jialing" }, {"name": "March 19, 2008", "start": 1205856000, "end": 1205942399 }, "China's basic medical insurance program will cover all urban residents in the country by the end of this year, the State Council of China announced recently. \r\n", "http://www.pharmasianews.com/fdcreports/story/viewStory.do?targetGUID={2C8EDE00-D777-4B2A-99ED-8851D23312CF}&AuthToken=2124020531", 493]},
{"_name": "Chinese Simcere Reports Fourth Quarter Sales Growth; Preparing For Health Care Reforms", "_id": 726903, "_link": "http://tromblyltd.dabbledb.com/dabble/reports?view=793332&entry=726903",  "values": ["Chinese Simcere Reports Fourth Quarter Sales Growth; Preparing For Health Care Reforms", {"_id": 79435, "_name": "Dai Jialing" }, {"name": "March 17, 2008", "start": 1205683200, "end": 1205769599 }, "China-based Simcere Pharmaceutical Group reported a spike in the sales of its two main products, anti-cancer drug Endu and injectable edaravone Bicun in its fourth quarter 2007 financial results.", "http://www.pharmasianews.com/fdcreports/story/viewStory.do?targetGUID={A38B4E4D-9113-4169-B0D6-9EEEAB4DB121}&AuthToken=-861695888", 592]},
{"_name": "First NYSE-listed TCM Firm Faces Buyout", "_id": 734687, "_link": "http://tromblyltd.dabbledb.com/dabble/reports?view=793332&entry=734687",  "values": ["First NYSE-listed TCM Firm Faces Buyout", {"_id": 497687, "_name": "Ying Huang" }, {"name": "March 17, 2008", "start": 1205683200, "end": 1205769599 }, "", "http://www.pharmasianews.com/fdcreports/story/viewStory.do?targetAN=28080316003#_st0", 494]},
{"_name": "Indian Nutraceutical Regulation Reflects Blurred Food/Drug", "_id": 715938, "_link": "http://tromblyltd.dabbledb.com/dabble/reports?view=793332&entry=715938",  "values": ["Indian Nutraceutical Regulation Reflects Blurred Food/Drug", {"_id": 580020, "_name": "Mayur Pahilajani" }, {"name": "March 12, 2008", "start": 1205251200, "end": 1205337599 }, "MUMBAI - Indian authorities are struggling to establish \r\n                  standardized regulations and policies to promote the \r\n                  development of quality nutraceutical products and address \r\n                  claims and labeling issues. \r\n", "http://www.pharmasianews.com/fdcreports/story/viewStory.do?targetAN=28080312006#_st0", 594]},
{"_name": "U.S. TCM Company Acquires Chinese Firm’s Product Line", "_id": 722921, "_link": "http://tromblyltd.dabbledb.com/dabble/reports?view=793332&entry=722921",  "values": ["U.S. TCM Company Acquires Chinese Firm’s Product Line", {"_id": 79435, "_name": "Dai Jialing" }, {"name": "March 12, 2008", "start": 1205251200, "end": 1205337599 }, "", "http://www.pharmasianews.com/fdcreports/story/viewStory.do?targetGUID={19633DE6-31FC-4613-A307-125BBE229BF1}&CID_RESET_TOKEN=true&AuthToken=-1322579324", 347]},
{"_name": "Huya’s Foreign Clinical Advisory Team Includes Topol, Kowey", "_id": 728914, "_link": "http://tromblyltd.dabbledb.com/dabble/reports?view=793332&entry=728914",  "values": ["Huya’s Foreign Clinical Advisory Team Includes Topol, Kowey", {"_id": 497687, "_name": "Ying Huang" }, {"name": "March 11, 2008", "start": 1205164800, "end": 1205251199 }, "", "http://www.pharmasianews.com/fdcreports/story/viewStory.do?targetGUID={2BBED0B1-46ED-441F-8D71-B9B54BCE976B}", 642]},
{"_name": "Teijin's Novel Gout Drug To Launch In Europe", "_id": 716012, "_link": "http://tromblyltd.dabbledb.com/dabble/reports?view=793332&entry=716012",  "values": ["Teijin's Novel Gout Drug To Launch In Europe", {"_id": 42100, "_name": "Frances Wang" }, {"name": "March 8, 2008", "start": 1204905600, "end": 1204991999 }, "", "http://www.pharmasianews.com/fdcreports/story/viewStory.do?targetGUID={5A6C9F58-EA2A-4E16-BF88-BD9499227F21}", 323]},
{"_name": "Partnering Trend With Big Pharma And Indian Companies On The Rise In Race For Discovery", "_id": 695757, "_link": "http://tromblyltd.dabbledb.com/dabble/reports?view=793332&entry=695757",  "values": ["Partnering Trend With Big Pharma And Indian Companies On The Rise In Race For Discovery", {"_id": 593042, "_name": "Vipin Agnihotri" }, {"name": "March 7, 2008", "start": 1204819200, "end": 1204905599 }, " NEW DELHI - Chemical expertise, emerging R&D work and growing \r\n                  awareness of intellectual property rights are propelling \r\n                  foreign companies to seek collaborative agreements with Indian \r\n                  firms to develop new chemical entities, according to analysts. \r\n", "http://www.pharmasianews.com/fdcreports/story/viewStory.do?targetGUID={A1CAC7A5-FEFD-47B8-97B1-FBEFE42692B6}", 410]},
{"_name": "Beijing FDA To Establish Early Adverse Event Warning System", "_id": 715644, "_link": "http://tromblyltd.dabbledb.com/dabble/reports?view=793332&entry=715644",  "values": ["Beijing FDA To Establish Early Adverse Event Warning System", {"_id": 497687, "_name": "Ying Huang" }, {"name": "March 7, 2008", "start": 1204819200, "end": 1204905599 }, "", "http://www.pharmasianews.com/fdcreports/story/viewStory.do?targetGUID={06993704-D5AB-4C93-B8BB-3BFACA69E2C3}", 472]},
{"_name": "Rising Glucose Demand Pads Bottom Line Of Shengtai Pharmaceutical", "_id": 712111, "_link": "http://tromblyltd.dabbledb.com/dabble/reports?view=793332&entry=712111",  "values": ["Rising Glucose Demand Pads Bottom Line Of Shengtai Pharmaceutical", {"_id": 497687, "_name": "Ying Huang" }, {"name": "March 4, 2008", "start": 1204560000, "end": 1204646399 }, "", "http://www.pharmasianews.com/fdcreports/story/viewStory.do?targetGUID={5090B53C-FA17-4082-B5A6-F8AFFDB6EB0E}", 526]},
{"_name": "Rhei To Market A Nutraceutical Attental In China", "_id": 694173, "_link": "http://tromblyltd.dabbledb.com/dabble/reports?view=793332&entry=694173",  "values": ["Rhei To Market A Nutraceutical Attental In China", {"_id": 497687, "_name": "Ying Huang" }, {"name": "February 28, 2008", "start": 1204128000, "end": 1204214399 }, "Rhei Pharmaceuticals and MethaPharma have inked a deal under which Rhei gains exclusive rights to market and distribute MethaPharma's proprietary nutraceutical product Attental for treating attention-deficit hyperactivity disorder throughout Asia, the two companies announced Feb. 19.", "http://www.pharmasianews.com/fdcreports/story/viewStory.do?targetGUID={25A84C72-1E2C-4314-A222-BECF0101162D}", 774]},
{"_name": "China State FDA Issues Warning In Wake Of Heparin Safety Concerns", "_id": 710192, "_link": "http://tromblyltd.dabbledb.com/dabble/reports?view=793332&entry=710192",  "values": ["China State FDA Issues Warning In Wake Of Heparin Safety Concerns", {"_id": 79435, "_name": "Dai Jialing" }, {"name": "February 28, 2008", "start": 1204128000, "end": 1204214399 }, "In the wake of a U.S. safety scare related to Baxter Healthcare's heparin, China's State FDA has warned foreign pharmaceutical companies to conduct business with only licensed Chinese companies. ", "http://www.pharmasianews.com/fdcreports/story/viewStory.do?targetGUID={EE966C8D-32DF-4566-B9BB-CED9D332B255}&CID_RESET_TOKEN=true&AuthToken=-1504850886", 419]},
{"_name": "On-line Clinical Management Course Opens Doors For Chinese CROs To Enter Global Markets", "_id": 677957, "_link": "http://tromblyltd.dabbledb.com/dabble/reports?view=793332&entry=677957",  "values": ["On-line Clinical Management Course Opens Doors For Chinese CROs To Enter Global Markets", {"_id": 79435, "_name": "Dai Jialing" }, {"name": "February 27, 2008", "start": 1204041600, "end": 1204127999 }, "Rockville, Md.-based contract research organization Global Research Services is collaborating with the University of Rochester Medical Center to launch an on-line clinical trial management training course in China this summer. ", "http://www.pharmasianews.com/fdcreports/story/viewStory.do?targetAN=28080226001#_st0", 401]},
{"_name": "China Shenghuo Gains Foothold In U.S. Market With TCM Products", "_id": 680023, "_link": "http://tromblyltd.dabbledb.com/dabble/reports?view=793332&entry=680023",  "values": ["China Shenghuo Gains Foothold In U.S. Market With TCM Products", {"_id": 497687, "_name": "Ying Huang" }, {"name": "February 25, 2008", "start": 1203868800, "end": 1203955199 }, "China Shenghuo Pharmaceutical will launch its new traditional Chinese medicine-based 12Ways Skin Care products in the U.S. during the first quarter of 2008, the company announced Feb. 7.", "http://www.pharmasianews.com/fdcreports/story/viewStory.do?targetGUID={ADB150EA-FCF2-4F8D-97CF-4815D004DD25}&AuthToken=63344564", 506]},
{"_name": "Charles River Labs To Provide Western-Standard GLP Services in China", "_id": 688171, "_link": "http://tromblyltd.dabbledb.com/dabble/reports?view=793332&entry=688171",  "values": ["Charles River Labs To Provide Western-Standard GLP Services in China", {"_id": 79435, "_name": "Dai Jialing" }, {"name": "February 25, 2008", "start": 1203868800, "end": 1203955199 }, "Charles River Laboratories is expanding its operations in China with Western-standard discovery and good laboratory practice services that will enable it to conduct studies suitable to submit to regulators in the U.S., Europe and China, the company said Feb 20.", "http://www.pharmasianews.com/fdcreports/story/viewStory.do?targetGUID={6BB7688D-FE83-4E5F-A0D6-696DCCF09048}", 450]},
{"_name": "Taisho to merge Biofermin", "_id": 678876, "_link": "http://tromblyltd.dabbledb.com/dabble/reports?view=793332&entry=678876",  "values": ["Taisho to merge Biofermin", {"_id": 42100, "_name": "Frances Wang" }, {"name": "February 20, 2008", "start": 1203436800, "end": 1203523199 }, "Tokyo-based Taisho Pharmaceutical will take its first steps into the lactic acid bacteria drugs market following its proposed acquisition of Kobe, Japan-based Biofermin Pharmaceutical, approved by the latter's board Feb. 12.", "http://www.pharmasianews.com/fdcreports/story/viewStory.do?targetAN=28080220001#_st0", 324]},
{"_name": "Chinese Heparin API Manufacturer Not Inspected By SFDA", "_id": 680379, "_link": "http://tromblyltd.dabbledb.com/dabble/reports?view=793332&entry=680379",  "values": ["Chinese Heparin API Manufacturer Not Inspected By SFDA", {"_id": 79435, "_name": "Dai Jialing" }, {"name": "February 18, 2008", "start": 1203264000, "end": 1203350399 }, "China's State FDA has never inspected an API manufacturer that may be linked to a safety scare over Baxter Healthcare's injectable heparin, officials confirmed to PharmAsia News.", "http://www.pharmasianews.com/fdcreports/story/viewStory.do?targetGUID={8E46066F-6237-4185-97D6-F507183C8F20}&CID_RESET_TOKEN=true&AuthToken=2040536339", 254]},
{"_name": "NPA, USP Provide GMP Support To Chinese Dietary Supplement Suppliers", "_id": 618629, "_link": "http://tromblyltd.dabbledb.com/dabble/reports?view=793332&entry=618629",  "values": ["NPA, USP Provide GMP Support To Chinese Dietary Supplement Suppliers", {"_id": 79435, "_name": "Dai Jialing" }, {"name": "February 14, 2008", "start": 1202918400, "end": 1203004799 }, "All dietary supplements marketed in the U.S. will need to adhere to new Good Manufacturing Practices by the end of June 2010, National Products Association VP - Scientific and Regulatory Affairs Daniel Fabricant told a recent seminar in Shanghai. ", "http://www.pharmasianews.com/fdcreports/story/viewStory.do?targetGUID={340FEEDA-505C-4446-AFBC-CC92EA37E9CB}&CID_RESET_TOKEN=true&AuthToken=-916768866", 712]},
{"_name": "MHLW to learn pharmaceutical system overseas", "_id": 652212, "_link": "http://tromblyltd.dabbledb.com/dabble/reports?view=793332&entry=652212",  "values": ["MHLW to learn pharmaceutical system overseas", {"_id": 42100, "_name": "Frances Wang" }, {"name": "February 14, 2008", "start": 1202918400, "end": 1203004799 }, "Japan's Ministry of Health, Labor and Welfare will send a research group to the U.S., U.K. and France in February, to study price setting and logistical systems being used in the pharmaceutical industries there, the MHLW announced Jan. 29.The research will focus on how to promote generic drugs in Japan to bring new ideas to the drug re-pricing discussions in April, said the MHLW.", "http://www.pharmasianews.com/fdcreports/story/viewStory.do?targetAN=28080214001&CID_RESET_TOKEN=true&AuthToken=733966950", 455]},
{"_name": "U.S.-Based PPD Inks Deal With Peking Biomedical, Expands Lab Services", "_id": 642334, "_link": "http://tromblyltd.dabbledb.com/dabble/reports?view=793332&entry=642334",  "values": ["U.S.-Based PPD Inks Deal With Peking Biomedical, Expands Lab Services", {"_id": 497687, "_name": "Ying Huang" }, {"name": "February 8, 2008", "start": 1202400000, "end": 1202486399 }, "U.S.-based Pharmaceutical Product Development inked an exclusive deal with Peking Union Lawke Biomedical Development Limited to expand its global central lab services in China, the company announced Jan. 23. ", "http://www.pharmasianews.com/fdcreports/story/viewStory.do?targetGUID={070139D7-5AA3-42B0-8608-25841F08E7C2}", 536]},
{"_name": "U.S. FDA Issues Warning Letter To Tomita For GMP Deficiencies", "_id": 637454, "_link": "http://tromblyltd.dabbledb.com/dabble/reports?view=793332&entry=637454",  "values": ["U.S. FDA Issues Warning Letter To Tomita For GMP Deficiencies", {"_id": 42100, "_name": "Frances Wang" }, {"name": "February 7, 2008", "start": 1202313600, "end": 1202399999 }, "", null, 441]},
{"_name": "China Moves 30 Drugs OTC, Encourages Nonprescription Switches", "_id": 634985, "_link": "http://tromblyltd.dabbledb.com/dabble/reports?view=793332&entry=634985",  "values": ["China Moves 30 Drugs OTC, Encourages Nonprescription Switches", {"_id": 497687, "_name": "Ying Huang" }, {"name": "February 1, 2008", "start": 1201795200, "end": 1201881599 }, "China's State FDA assigned 30 drugs over-the-counter status in a notice issued Jan. 11, reflecting the agency's interest in expanding availability of nonprescription drugs to help reduce health care costs. ", "http://www.pharmasianews.com/fdcreports/story/viewStory.do?targetGUID={5A0335C8-B0EF-440E-9BEF-EBD3DEC0C4CF}", 534]},
{"_name": "Benda's Jiangling Plant Gets Production Approval", "_id": 624146, "_link": "http://tromblyltd.dabbledb.com/dabble/reports?view=793332&entry=624146",  "values": ["Benda's Jiangling Plant Gets Production Approval", {"_id": 79435, "_name": "Dai Jialing" }, {"name": "January 30, 2008", "start": 1201622400, "end": 1201708799 }, "", null, 647]},
{"_name": "Wyeth Gets Exclusive License For Mochida's Painkiller Drug", "_id": 595099, "_link": "http://tromblyltd.dabbledb.com/dabble/reports?view=793332&entry=595099",  "values": ["Wyeth Gets Exclusive License For Mochida's Painkiller Drug", {"_id": 42100, "_name": "Frances Wang" }, {"name": "January 27, 2008", "start": 1201363200, "end": 1201449599 }, "Wyeth has acquired global rights to Mochida Pharmaceutical's preclinical transient receptor potential vanilloid sub-family 1 (TRPV-1) antagonist molecule for treating pain, the companies announced Jan 9. ", "http://www.pharmasianews.com/fdcreports/story/viewStory.do?targetGUID={C1667664-7FE6-4932-A576-1872930D6C9B}", 407]},
{"_name": "Teva To Expand Its Indian Presence", "_id": 593033, "_link": "http://tromblyltd.dabbledb.com/dabble/reports?view=793332&entry=593033",  "values": ["Teva To Expand Its Indian Presence", {"_id": 593042, "_name": "Vipin Agnihotri" }, {"name": "January 24, 2008", "start": 1201104000, "end": 1201190399 }, "Israeli pharmaceutical company Teva Pharmaceutical will invest more than $1 billion in India over the next two years to establish greenfield manufacturing facilities and acquire Indian drug companies, said a Jan. 10 report in the local newspaper Business Standard.\r\n", "http://www.pharmasianews.com/fdcreports/story/viewStory.do?targetGUID={1299B055-3105-41AD-BB82-5CD02D1F1992}&AuthToken=-522790279", 343]},
{"_name": "Unigene and Shijiazhuang Pharmaceutical Group to Expand Chinese Joint Venture", "_id": 586817, "_link": "http://tromblyltd.dabbledb.com/dabble/reports?view=793332&entry=586817",  "values": ["Unigene and Shijiazhuang Pharmaceutical Group to Expand Chinese Joint Venture", {"_id": 79435, "_name": "Dai Jialing" }, {"name": "January 23, 2008", "start": 1201017600, "end": 1201103999 }, "Unigene Laboratories and Shijiazhuang Pharmaceutical Group will establish the SPG-Unigene Biotechnology Research Institute under a newly expanded joint venture in China, Unigene announced on Jan. 8. ", "http://www.pharmasianews.com/fdcreports/story/viewStory.do?targetGUID={D2207689-42F2-44DE-9CA3-696CF6867A7B}", 462]},
{"_name": "BASF Establishes Development Centers In Shanghai", "_id": 611105, "_link": "http://tromblyltd.dabbledb.com/dabble/reports?view=793332&entry=611105",  "values": ["BASF Establishes Development Centers In Shanghai", {"_id": 497687, "_name": "Ying Huang" }, {"name": "January 23, 2008", "start": 1201017600, "end": 1201103999 }, "BASF AG has established three development centers in Shanghai to develop pharmaceutical ingredients and finished products, the German company announced Jan. 16.", "http://www.pharmasianews.com/fdcreports/story/viewStory.do?targetGUID={D4EEE9F3-AEA9-439C-AF2F-D1D50085982A}&AuthToken=-2069237727", 476]},
{"_name": "China Biopharmaceutical Industry Will Grow To $17 Billion By 2015 - ResearchInChina Report", "_id": 582817, "_link": "http://tromblyltd.dabbledb.com/dabble/reports?view=793332&entry=582817",  "values": ["China Biopharmaceutical Industry Will Grow To $17 Billion By 2015 - ResearchInChina Report", {"_id": 79435, "_name": "Dai Jialing" }, {"name": "January 19, 2008", "start": 1200672000, "end": 1200758399 }, "Production value of the Chinese pharmaceutical industry has grown at an annual average of 20 percent over the past decade, according to ResearchInChina's 2007-2008 China Biopharmaceutical Industry Report, issued in December. ", "http://www.pharmasianews.com/fdcreports/story/viewStory.do?targetGUID={020706CD-93C7-46C5-BEDC-D176C66AA44F}&AuthToken=676367997", 403]},
{"_name": "Gardasil, Cervarix Could Be Approved This Year In Japan", "_id": 586362, "_link": "http://tromblyltd.dabbledb.com/dabble/reports?view=793332&entry=586362",  "values": ["Gardasil, Cervarix Could Be Approved This Year In Japan", {"_id": 42100, "_name": "Frances Wang" }, {"name": "January 19, 2008", "start": 1200672000, "end": 1200758399 }, "Gardasil and Cervarix, cervical cancer vaccines manufactured by Merck and GlaxoSmithKline, respectively, could be approved for use this year in Japan.\r\nBanyu Pharmaceutical, Merck's Japanese subsidiary, filed its application for approval in November.", "http://www.pharmasianews.com/fdcreports/story/viewStory.do?targetAN=28080119005#_st0", 455]},
{"_name": "Quintiles Expands Operations In China", "_id": 592036, "_link": "http://tromblyltd.dabbledb.com/dabble/reports?view=793332&entry=592036",  "values": ["Quintiles Expands Operations In China", {"_id": 497687, "_name": "Ying Huang" }, {"name": "January 18, 2008", "start": 1200585600, "end": 1200671999 }, "Quintiles Transnational will move its Global Central Laboratories and Clinical Development Services (CDS) units in Beijing to a larger facility to meet growing demands in China, the company announced Jan. 9. ", "http://www.pharmasianews.com/fdcreports/story/viewStory.do?targetGUID={6F465873-0992-4D7D-BBCB-85F0A4EEDB94}", 503]},
{"_name": "WuXi PharmaTech to Acquire AppTec Laboratory Services, Inc.", "_id": 554839, "_link": "http://tromblyltd.dabbledb.com/dabble/reports?view=793332&entry=554839",  "values": ["WuXi PharmaTech to Acquire AppTec Laboratory Services, Inc.", {"_id": 497687, "_name": "Ying Huang" }, {"name": "January 15, 2008", "start": 1200326400, "end": 1200412799 }, "WuXi PharmaTech will acquire U.S.-based AppTec Laboratory Services, theChinese pharma outsourcing company announced Jan. 3. ", "http://www.pharmasianews.com/fdcreports/story/viewStory.do?targetGUID={F42244DF-3116-4AF7-8FAD-78E206738624}", 425]},
{"_name": "China's State FDA Enforces New Rules For Traditional Chinese Medicine Registration", "_id": 580118, "_link": "http://tromblyltd.dabbledb.com/dabble/reports?view=793332&entry=580118",  "values": ["China's State FDA Enforces New Rules For Traditional Chinese Medicine Registration", {"_id": 497687, "_name": "Ying Huang" }, {"name": "January 15, 2008", "start": 1200326400, "end": 1200412799 }, "China's State FDA introduced new supplementary requirements for registering traditional Chinese medicine Jan. 8, to separate the process from western drug registration. ", "http://www.pharmasianews.com/fdcreports/story/viewStory.do?targetGUID={CC284326-474D-4731-AC6B-6F4C1CB47ADA}", 450]},
{"_name": "Novartis Subsidiary Acquires Grunenthal Factory To Boost Generics Production In China", "_id": 518409, "_link": "http://tromblyltd.dabbledb.com/dabble/reports?view=793332&entry=518409",  "values": ["Novartis Subsidiary Acquires Grunenthal Factory To Boost Generics Production In China", {"_id": 497687, "_name": "Ying Huang" }, {"name": "January 13, 2008", "start": 1200153600, "end": 1200239999 }, "Novartis subsidiary Sandoz China has acquired a manufacturing facility from Grunenthal Pharmaceutical China to establish a new company to manufacture generic drugs in China, Sandoz announced in late December. ", "http://www.pharmasianews.com/fdcreports/story/viewStory.do?targetGUID={477D1164-D228-4246-A856-C9FAEF176AD6}", 415]},
{"_name": "Asymchem To Build GMP Manufacturing Facility In Tianjin", "_id": 538283, "_link": "http://tromblyltd.dabbledb.com/dabble/reports?view=793332&entry=538283",  "values": ["Asymchem To Build GMP Manufacturing Facility In Tianjin", {"_id": 497687, "_name": "Ying Huang" }, {"name": "January 10, 2008", "start": 1199894400, "end": 1199980799 }, "Asymchem will build a 100,000 sqm facility in the Dagang Development Zone (DEDA) of Tianjin, North China, to produce cGMP intermediates and active pharmaceutical ingredients, the company announced Dec. 27. ", "http://www.pharmasianews.com/fdcreports/story/viewStory.do?targetGUID={E6931622-9950-47D3-B23A-2EDE0A815ABC}&AuthToken=-23595783", 420]},
{"_name": "Japanese Regulators Enforce Label Change For Flu Drugs Due To Abnormal Behavior", "_id": 532369, "_link": "http://tromblyltd.dabbledb.com/dabble/reports?view=793332&entry=532369",  "values": ["Japanese Regulators Enforce Label Change For Flu Drugs Due To Abnormal Behavior", {"_id": 42100, "_name": "Frances Wang" }, {"name": "January 9, 2008", "start": 1199808000, "end": 1199894399 }, "Drugs containing zanamivir hydrate or amantadine hydrochloride,ingredients commonly used in anti-influenza treatments, will have to change their labels immediately, Japan's Ministry of Health, Labour and Welfare (MHLW) announced Dec. 26.", "http://www.pharmasianews.com/fdcreports/story/viewStory.do?targetAN=28080109006#_st0", 400]},
{"_name": "Undeclared APIs In ED Supplements From China Prompt FDA Warning", "_id": 510908, "_link": "http://tromblyltd.dabbledb.com/dabble/reports?view=793332&entry=510908",  "values": ["Undeclared APIs In ED Supplements From China Prompt FDA Warning", {"_id": 79435, "_name": "Dai Jialing" }, {"name": "January 7, 2008", "start": 1199635200, "end": 1199721599 }, "SHANGHAI - The U.S. FDA warned consumers Dec. 28 about using erectile dysfunction dietary supplements produced in China because some products contained undeclared active pharmaceutical ingredients. ", "http://www.pharmasianews.com/fdcreports/story/viewStory.do?targetGUID={BF0053C7-CFB4-4789-8E0C-01F6694A26A2}", 409]},
{"_name": "China Pharmaceutical Association Official Sentenced To Seven Years Imprisonment For Corruption Charges", "_id": 519454, "_link": "http://tromblyltd.dabbledb.com/dabble/reports?view=793332&entry=519454",  "values": ["China Pharmaceutical Association Official Sentenced To Seven Years Imprisonment For Corruption Charges", {"_id": 497687, "_name": "Ying Huang" }, {"name": "January 7, 2008", "start": 1199635200, "end": 1199721599 }, "SHANGHAI - The former deputy secretary general of the China Pharmaceutical Association was sentenced to seven years in jail by Beijing's Xicheng District Court Dec. 31 for taking bribes amounting to 160,000 yuan ($22,000). ", "http://www.pharmasianews.com/fdcreports/story/viewStory.do?targetGUID={C55FEE60-98C2-4678-B0DF-EB1D6274EE4C}", 466]},
{"_name": "MPI Research and Shanghai Medicilon Announce Shanghai-Based Joint Venture", "_id": 496227, "_link": "http://tromblyltd.dabbledb.com/dabble/reports?view=793332&entry=496227",  "values": ["MPI Research and Shanghai Medicilon Announce Shanghai-Based Joint Venture", {"_id": 79435, "_name": "Dai Jialing" }, {"name": "January 2, 2008", "start": 1199203200, "end": 1199289599 }, "SHANGHAI – Michigan-based MPI Research has entered into a joint venture with Shanghai Medicilon to establish a preclinical research center in Shanghai that meets U.S. FDA and other international regulatory standards, the companies announced Dec 19.", "http://www.pharmasianews.com/2008/01/mpi-research-an.html", 430]},
{"_name": "Medivir Transfers HIV Drug Alovudine License To Beijing Mefuvir", "_id": 501425, "_link": "http://tromblyltd.dabbledb.com/dabble/reports?view=793332&entry=501425",  "values": ["Medivir Transfers HIV Drug Alovudine License To Beijing Mefuvir", {"_id": 497687, "_name": "Ying Huang" }, {"name": "January 2, 2008", "start": 1199203200, "end": 1199289599 }, "SHANGHAI – Sweden-based Medivir AB will transfer its license and intellectual property for its HIV drug Alovudine (MIV-310) to subsidiary Beijing Mefuvir, Medivir announced Dec. 21.", "http://www.pharmasianews.com/2008/01/medivir-transfe.html", 435]},
{"_name": "Merck Recalls HIB Vaccines In China", "_id": 465248, "_link": "http://tromblyltd.dabbledb.com/dabble/reports?view=793332&entry=465248",  "values": ["Merck Recalls HIB Vaccines In China", {"_id": 497687, "_name": "Ying Huang" }, {"name": "December 27, 2007", "start": 1198684800, "end": 1198771199 }, "SHANGHAI - Merck recalled more than 100,000 doses of its HIB vaccines exported to China, as part of its global initiative to recall certain lots of PedvaxHIB and Comvax vaccines due to sterilization concerns.", "http://www.pharmasianews.com/2007/12/merck-recalls-h.html", 410]},
{"_name": "Chinese Device Maker Weigao Banks On Medtronic’s Brand Name For International Backbone", "_id": 468556, "_link": "http://tromblyltd.dabbledb.com/dabble/reports?view=793332&entry=468556",  "values": ["Chinese Device Maker Weigao Banks On Medtronic’s Brand Name For International Backbone", {"_id": 42100, "_name": "Frances Wang" }, {"name": "December 27, 2007", "start": 1198684800, "end": 1198771199 }, "SHANGHAI - A new joint venture formed with Medtronic will give Chinese device maker Weigao the international presence it needs to bring the international market to its orthopedic products. ", "http://www.pharmasianews.com/2007/12/chinese-device.html", 455]},
{"_name": "Novelos Inks Deal With Hong Kong-Based Lee’s Pharma For Cancer, Hepatitis Compounds", "_id": 468638, "_link": "http://tromblyltd.dabbledb.com/dabble/reports?view=793332&entry=468638",  "values": ["Novelos Inks Deal With Hong Kong-Based Lee’s Pharma For Cancer, Hepatitis Compounds", {"_id": 42100, "_name": "Frances Wang" }, {"name": "December 27, 2007", "start": 1198684800, "end": 1198771199 }, "SHANGHAI - Novelos Therapeutics signed an exclusive license agreement with Hong Kong-based Lee's Pharmaceutical Dec. 17, with an aim to expand the sales of its cancer and hepatitis compounds - NOV-002 and NOV205 - in the Greater China region.", "http://www.pharmasianews.com/2007/12/novelos-inks-de.html", 524]},
{"_name": "Shanghai FDA Withdraws GMP Certificates, Suspends Production Of Drug Makers As Part Of “Five Links” Program", "_id": 472748, "_link": "http://tromblyltd.dabbledb.com/dabble/reports?view=793332&entry=472748",  "values": ["Shanghai FDA Withdraws GMP Certificates, Suspends Production Of Drug Makers As Part Of “Five Links” Program", {"_id": 79435, "_name": "Dai Jialing" }, {"name": "December 27, 2007", "start": 1198684800, "end": 1198771199 }, "SHANGAHI - Shanghai FDA withdrew two GMP certificates and suspended the production of two companies in an action to enhance compliance with drug and device manufacturers through its “five links” program, the Shanghai government announced Dec. 10.", "http://www.pharmasianews.com/2007/12/shanghai-fda-wi.html", 463]},
{"_name": "China Nepstar Signs 16 Cooperative Agreements With Multinational, Domestic Partners", "_id": 476754, "_link": "http://tromblyltd.dabbledb.com/dabble/reports?view=793332&entry=476754",  "values": ["China Nepstar Signs 16 Cooperative Agreements With Multinational, Domestic Partners", {"_id": 497687, "_name": "Ying Huang" }, {"name": "December 27, 2007", "start": 1198684800, "end": 1198771199 }, "SHANGHAI - China Nepstar Chain Drugstore signed strategic cooperative agreements with 16 pharmaceutical and health products suppliers as part of its store network expansion plan for 2008, the drugstore chain announced Dec. 14. ", "http://www.pharmasianews.com/fdcreports/story/viewStory.do?targetGUID={BDD2F9FA-2F2A-4642-9441-94000392677D}", 264]},
{"_name": "China’s SFDA Cancels Drug Maker’s License Following Investigation Of Tainted Products", "_id": 467334, "_link": "http://tromblyltd.dabbledb.com/dabble/reports?view=793332&entry=467334",  "values": ["China’s SFDA Cancels Drug Maker’s License Following Investigation Of Tainted Products", {"_id": 79435, "_name": "Dai Jialing" }, {"name": "December 20, 2007", "start": 1198080000, "end": 1198166399 }, "SHANGHAI – China’s State FDA withdrew Shanghai Hualian Pharmaceutical's drug production license because the company’s two leukemia drugs were found to be contaminated and caused considerable damage to patients, the drug safety watchdog announced at a Dec. 12 press conference in Beijing.", "http://www.pharmasianews.com/2007/12/chinas-sfda-can.html", 354]},
{"_name": "Australia’s Helicon and China’s Jewim Pharmaceuticals Partner To Fill Unmet Needs In China", "_id": 460794, "_link": "http://tromblyltd.dabbledb.com/dabble/reports?view=793332&entry=460794",  "values": ["Australia’s Helicon and China’s Jewim Pharmaceuticals Partner To Fill Unmet Needs In China", {"_id": 497687, "_name": "Ying Huang" }, {"name": "December 17, 2007", "start": 1197820800, "end": 1197907199 }, "Australia-based Helicon Group entered into a cooperative agreement with China’s Jewim Pharmaceuticals Dec. 10, to bring new biomedical technologies to the Chinese market.", "http://www.pharmasianews.com/2007/12/australias-heli.html", 537]},
{"_name": "Lucrative Conference: Benda Recognizes $1.3 Million For Gendicine Order", "_id": 428224, "_link": "http://tromblyltd.dabbledb.com/dabble/reports?view=793332&entry=428224",  "values": ["Lucrative Conference: Benda Recognizes $1.3 Million For Gendicine Order", {"_id": 79435, "_name": "Dai Jialing" }, {"name": "December 13, 2007", "start": 1197475200, "end": 1197561599 }, "Benda has recognized $1.3 million in revenues from an order worth $3.8 million placed at a recent conference for its cancer gene therapy Gendicine, the company announced Dec 5.", "http://www.pharmasianews.com/2007/12/lucrative-confe.html", 348]},
{"_name": "China's SFDA Bans 300 Drug and Device Manufacturers", "_id": 448202, "_link": "http://tromblyltd.dabbledb.com/dabble/reports?view=793332&entry=448202",  "values": ["China's SFDA Bans 300 Drug and Device Manufacturers", {"_id": 497687, "_name": "Ying Huang" }, {"name": "December 13, 2007", "start": 1197475200, "end": 1197561599 }, "China’s State Food and Drug Administration shut down nearly 300 drug and device manufacturers as part of its nationwide campaign to increase compliance standards in pharmaceutical production, the drug watchdog said in a Dec. 3 press conference held by the State Council Information Office in Beijing.", "http://www.pharmasianews.com/2007/12/chinas-sfda-ban.html", 505]},
{"_name": "Sanofi To Establish New Vaccine Production Facility In Shenzhen", "_id": 402929, "_link": "http://tromblyltd.dabbledb.com/dabble/reports?view=793332&entry=402929",  "values": ["Sanofi To Establish New Vaccine Production Facility In Shenzhen", {"_id": 79435, "_name": "Dai Jialing" }, {"name": "December 10, 2007", "start": 1197216000, "end": 1197302399 }, "French drug maker Sanofi Aventis will build a new vaccine manufacturing facility in Shenzhen to make influenza vaccine for the Chinese market, under an agreement it signed with Chinese authorities in Beijing Nov. 26.", "http://www.pharmasianews.com/2007/12/sanofi-to-estab.html", 522]},
{"_name": "China State FDA Recommends Death Penalty For Drug Counterfeiters", "_id": 414618, "_link": "http://tromblyltd.dabbledb.com/dabble/reports?view=793332&entry=414618",  "values": ["China State FDA Recommends Death Penalty For Drug Counterfeiters", {"_id": 497687, "_name": "Ying Huang" }, {"name": "December 10, 2007", "start": 1197216000, "end": 1197302399 }, "China’s State FDA released a draft judicial interpretation of new anti-drug counterfeiting laws Nov. 29, under which manufacturers and sellers of fake drugs that cause death or serious injury could be sentenced to death.", "http://www.pharmasianews.com/2007/12/china-state-fda.html", 638]},
{"_name": "Beijing Med Pharm To Exclusively Market Novartis’ Enablex In China", "_id": 419431, "_link": "http://tromblyltd.dabbledb.com/dabble/reports?view=793332&entry=419431",  "values": ["Beijing Med Pharm To Exclusively Market Novartis’ Enablex In China", {"_id": 497687, "_name": "Ying Huang" }, {"name": "December 10, 2007", "start": 1197216000, "end": 1197302399 }, "Beijing Med-Pharm (BMP) entered into an exclusive licensing agreement Nov. 26 with Novartis subsidiary Shanghai Novartis Trading Limited, for its bladder treatment drug Enablex (darifenacin) in China.", "http://www.pharmasianews.com/2007/12/beijing-med-pha.html", 551]},
{"_name": "Shortage Of Blood Products Means Record Sales For China Biologic Products", "_id": 374454, "_link": "http://tromblyltd.dabbledb.com/dabble/reports?view=793332&entry=374454",  "values": ["Shortage Of Blood Products Means Record Sales For China Biologic Products", {"_id": 497687, "_name": "Ying Huang" }, {"name": "December 3, 2007", "start": 1196611200, "end": 1196697599 }, "China Biologic Products announced record financial results for the quarter ending Sept. 30, despite declining sales volumes. ", "http://www.pharmasianews.com/2007/12/shortage-of-blo.html", 775]},
{"_name": "China’s State FDA Approves Aoxing R & D License For Anti-Opioid Addiction Drug", "_id": 374850, "_link": "http://tromblyltd.dabbledb.com/dabble/reports?view=793332&entry=374850",  "values": ["China’s State FDA Approves Aoxing R & D License For Anti-Opioid Addiction Drug", {"_id": 79435, "_name": "Dai Jialing" }, {"name": "December 3, 2007", "start": 1196611200, "end": 1196697599 }, "China’s State Food and Drug Administration approved a research and development license Nov. 20 for Aoxing Pharmaceutical's opioid combo tablet buprenorphine/naloxone tailored to fight the growing problem of opioid dependence in China. ", "http://www.pharmasianews.com/2007/12/chinas-state-fd.html", 680]},
{"_name": "Benda Anticipates 2008 Approval In India For Gene Therapy Product", "_id": 351790, "_link": "http://tromblyltd.dabbledb.com/dabble/reports?view=793332&entry=351790",  "values": ["Benda Anticipates 2008 Approval In India For Gene Therapy Product", {"_id": 79435, "_name": "Dai Jialing" }, {"name": "November 26, 2007", "start": 1196006400, "end": 1196092799 }, "China-Based Benda Pharmaceuticals anticipates 2008 approval from India’s Central Drugs Control Organization for its gene therapy product Gendicine for treatment of head and neck cancer. The company filed its application for the recombinant human Ad-p53 injection in November.", "http://www.pharmasianews.com/2007/11/bendas-anticipa.html", 597]},
{"_name": "Lilly Asian Ventures Looking For Chinese Companies To Invest In", "_id": 324908, "_link": "http://tromblyltd.dabbledb.com/dabble/reports?view=793332&entry=324908",  "values": ["Lilly Asian Ventures Looking For Chinese Companies To Invest In", {"_id": 497687, "_name": "Ying Huang" }, {"name": "November 19, 2007", "start": 1195401600, "end": 1195487999 }, "Lilly Asian Ventures will focus on directly investing into individual companies under its second phase of investment in China, the firm announced Nov.7 in Shanghai.", "http://www.pharmasianews.com/2007/11/lilly-asian-ven.html", 808]},
{"_name": "China Implements Credit Ratings System for Drug Advertising", "_id": 332990, "_link": "http://tromblyltd.dabbledb.com/dabble/reports?view=793332&entry=332990",  "values": ["China Implements Credit Ratings System for Drug Advertising", {"_id": 79435, "_name": "Dai Jialing" }, {"name": "November 19, 2007", "start": 1195401600, "end": 1195487999 }, "China’s State Food and Drug Administration announced Nov. 8 that it will implement new credit management measures to clamp down on illegal advertising of drugs, medical devices and health supplements.", "http://www.pharmasianews.com/2007/11/china-implement.html", 705]},
{"_name": "China's SFDA Sets New GMP Inspectional Guidelines", "_id": 294463, "_link": "http://tromblyltd.dabbledb.com/dabble/reports?view=793332&entry=294463",  "values": ["China's SFDA Sets New GMP Inspectional Guidelines", {"_id": 497687, "_name": "Ying Huang" }, {"name": "November 12, 2007", "start": 1194796800, "end": 1194883199 }, "China’s State Food and Drug Administration issued revised good manufacturing practice inspectional guidelines Oct. 24 in an effort to increase quality systems standards for pharmaceutical manufacturers. The new guidelines are scheduled to go into effect Jan. 1, replacing the current GMP inspectional guidelines, which were implemented in 1998.", "http://www.pharmasianews.com/2007/11/chinas-sfda-set.html", 708]},
{"_name": "Corrective Actions Lead Beijing FDA To Lift Drug Ad Suspensions, But SFDA Uncovers More Infractions", "_id": 307889, "_link": "http://tromblyltd.dabbledb.com/dabble/reports?view=793332&entry=307889",  "values": ["Corrective Actions Lead Beijing FDA To Lift Drug Ad Suspensions, But SFDA Uncovers More Infractions", {"_id": 79435, "_name": "Dai Jialing" }, {"name": "November 12, 2007", "start": 1194796800, "end": 1194883199 }, "China’s State Food and Drug Administration Nov. 7 issued a report summarizing illegal pharmaceutical and medical device advertisements uncovered by China’s local FDAs, and announced that advertising licenses for nine drugs and seven medical devices would be suspended for one year because of incorrect or exaggerated content.", "http://www.pharmasianews.com/2007/11/corrective-acti.html", 508734]},
{"_name": "Coca-Cola Sets Up Beijing Roots To Develop Chinese Herbal Products", "_id": 263778, "_link": "http://tromblyltd.dabbledb.com/dabble/reports?view=793332&entry=263778",  "values": ["Coca-Cola Sets Up Beijing Roots To Develop Chinese Herbal Products", {"_id": 497687, "_name": "Ying Huang" }, {"name": "November 5, 2007", "start": 1194192000, "end": 1194278399 }, "Coca-Cola preceded the opening of its first research center in China with extensive research on locally sourced traditional Chinese herbs and formulas, which it plans to use for products it will offer worldwide, the Atlanta-based beverage giant said Oct. 14.", "http://www.pharmasianews.com/2007/11/coca-cola-sets-.html", 573]},
{"_name": "Olympic Anti-Doping Measures Lead To Increased Inspections Of Chinese Drug Manufacturers And Pharmacies", "_id": 281548, "_link": "http://tromblyltd.dabbledb.com/dabble/reports?view=793332&entry=281548",  "values": ["Olympic Anti-Doping Measures Lead To Increased Inspections Of Chinese Drug Manufacturers And Pharmacies", {"_id": 79435, "_name": "Dai Jialing" }, {"name": "November 5, 2007", "start": 1194192000, "end": 1194278399 }, "Seven departments of the Chinese government initiated a program Oct. 18 to increase inspections of pharmacies and drug manufacturers in an effort to remove performance-enhancing substances from the OTC market in advance of next year’s Beijing Olympics, Chinese officials told PharmAsia News.", "http://www.pharmasianews.com/2007/11/olympic-anti-do.html", 755]},
{"_name": "Genzyme and Sunway collaborate gene therapy drugs in China", "_id": 289035, "_link": "http://tromblyltd.dabbledb.com/dabble/reports?view=793332&entry=289035",  "values": ["Genzyme and Sunway collaborate gene therapy drugs in China", {"_id": 497687, "_name": "Ying Huang" }, {"name": "November 5, 2007", "start": 1194192000, "end": 1194278399 }, "Genzyme and Sunway Biotech announced Oct. 25 a collaboration to develop, manufacture and commercialize Ad2/HIF-1a, an experimental gene therapy product, in China.", "http://www.pharmasianews.com/2007/11/genzyme-to-coll.html", 810]},
{"_name": "New Roche Development Center In Shanghai To Focus on Metabolic Diseases, Tumors", "_id": 293087, "_link": "http://tromblyltd.dabbledb.com/dabble/reports?view=793332&entry=293087",  "values": ["New Roche Development Center In Shanghai To Focus on Metabolic Diseases, Tumors", {"_id": 79435, "_name": "Dai Jialing" }, {"name": "November 5, 2007", "start": 1194192000, "end": 1194278399 }, "Roche formally opened its Pharma Development Center in China (PDCC) Oct. 29 in Shanghai, the Swiss company’s first comprehensive drug development center in the Asia-Pacific region, outside of Japan.", "http://www.pharmasianews.com/2007/11/new-roche-devel.html", 643]},
{"_name": "Anesiva Forms Joint Venture With Wanbang Biological", "_id": 250485, "_link": "http://tromblyltd.dabbledb.com/dabble/reports?view=793332&entry=250485",  "values": ["Anesiva Forms Joint Venture With Wanbang Biological", {"_id": 79435, "_name": "Dai Jialing" }, {"name": "October 31, 2007", "start": 1193760000, "end": 1193846399 }, "Anesiva entered into a joint venture Oct. 14 with Jiangsu Wanbang Biological Pharmaceutical Corp., a subsidiary of Shanghai Fosun Pharmaceuticals, to establish additional manufacturing capacity for the worldwide supply of its fast-acting topical local analgesia Zingo (lidocaine hydrochloride monohydrate).", "http://www.pharmasianews.com/2007/10/anesiva-forms-j.html", 636]},
{"_name": "Xian Janssen launches Remicade In China", "_id": 251034, "_link": "http://tromblyltd.dabbledb.com/dabble/reports?view=793332&entry=251034",  "values": ["Xian Janssen launches Remicade In China", {"_id": 79435, "_name": "Dai Jialing" }, {"name": "October 31, 2007", "start": 1193760000, "end": 1193846399 }, "Xian Janssen has launched the TNF inhibitor Remicade (infliximab) in China for use in the treatment of rheumatoid arthritis, ankyloing spondylitis and Crohn’s disease, the company announced Oct. 16.", "http://www.pharmasianews.com/2007/10/xian-janssen-la.html", 524]},
{"_name": "Pfizer Wins Trademark Lawsuit In China", "_id": 224978, "_link": "http://tromblyltd.dabbledb.com/dabble/reports?view=793332&entry=224978",  "values": ["Pfizer Wins Trademark Lawsuit In China", {"_id": 79435, "_name": "Dai Jialing" }, {"name": "October 22, 2007", "start": 1192982400, "end": 1193068799 }, "Pfizer won a trademark dispute against Beijing Herod Bio-tech Co. Sept. 24, with the First Intermediate Court of Beijing ordering Beijing Herod to pay Pfizer 200,000 yuan  ($26,666) for infringing Pfizer’s Chinese trademarks.", "http://www.pharmasianews.com/2007/10/pfizer-wins-tra.html", 720]},
{"_name": "Wuxi PharmaTech To Build Largest Preclinical Drug Safety Center In China", "_id": 232937, "_link": "http://tromblyltd.dabbledb.com/dabble/reports?view=793332&entry=232937",  "values": ["Wuxi PharmaTech To Build Largest Preclinical Drug Safety Center In China", {"_id": 497687, "_name": "Ying Huang" }, {"name": "October 22, 2007", "start": 1192982400, "end": 1193068799 }, "Chinese pharmaceutical R&D outsourcing services provider WuXi PharmaTech will invest $40 million to build its first good laboratory practices center in Suzhou. The GLP center will be the largest modern drug safety evaluation center in China, the New York Stock Exchange-listed company said Oct. 9.", "http://www.pharmasianews.com/2007/10/wuxi-pharmatech.html", 586]},
{"_name": "Beijing Med-Pharm to Acquire Sunstone Pharmaceutical", "_id": 193217, "_link": "http://tromblyltd.dabbledb.com/dabble/reports?view=793332&entry=193217",  "values": ["Beijing Med-Pharm to Acquire Sunstone Pharmaceutical", {"_id": 497687, "_name": "Ying Huang" }, {"name": "October 15, 2007", "start": 1192377600, "end": 1192463999 }, "Beijing Med-Pharm’s acquisition of Chinese OTC drug manufacturer Sunstone Pharmaceutical Co. will help it capitalize on the growing Chinese retail pharmacy space, BMP Chief Financial Officer Fred Powell said in an interview with PharmAsia News. ", "http://www.pharmasianews.com/2007/10/beijing-med-pha.html", 941]},
{"_name": "SFDA new fast track", "_id": 193526, "_link": "http://tromblyltd.dabbledb.com/dabble/reports?view=793332&entry=193526",  "values": ["SFDA new fast track", {"_id": 79435, "_name": "Dai Jialing" }, {"name": "October 15, 2007", "start": 1192377600, "end": 1192463999 }, "China regulators released a streamlined draft drug approval rule this month that would provide for faster approval of four categories of new drugs. The State Food and Drug Administration finished collecting public comments on the rule Oct. 15.  ", "http://www.pharmasianews.com/2007/10/sfda-drafts-new.html", 631]},
{"_name": "China To Fast-Track Approval For Hemophilia Drugs", "_id": 138277, "_link": "http://tromblyltd.dabbledb.com/dabble/reports?view=793332&entry=138277",  "values": ["China To Fast-Track Approval For Hemophilia Drugs", {"_id": 497687, "_name": "Ying Huang" }, {"name": "October 6, 2007", "start": 1191600000, "end": 1191686399 }, "In an effort to combat the domestic shortage of hemophilia treatments, China’s State Food and Drug Administration announced Sept. 18 that it will fast track the approval process for Bayer Healthcare’s Kogenate FS (recombinant-clotting factor VIII), which has had an application pending at SFDA since last November. ", "http://www.pharmasianews.com/2007/10/china-to-fast-t.html", 648]},
{"_name": "SFDA To Confirm Registrations For All Injectable Drugs", "_id": 87302, "_link": "http://tromblyltd.dabbledb.com/dabble/reports?view=793332&entry=87302",  "values": ["SFDA To Confirm Registrations For All Injectable Drugs", {"_id": 79435, "_name": "Dai Jialing" }, {"name": "October 2007", "start": 1191168000, "end": 1193846399 }, "China’s State Food and Drug Administration will review the registrations of all injectable drugs during the next ten months, and drugs whose manufacturing processes are not in line with their registration documents will have to halt production until the new processes are approved, under a notice issued Aug. 20.", "http://www.pharmasianews.com/2007/09/sfda-to-confirm.html", 740]},
{"_name": "China Drug Recall System Would Require 24-Hour Response", "_id": 137014, "_link": "http://tromblyltd.dabbledb.com/dabble/reports?view=793332&entry=137014",  "values": ["China Drug Recall System Would Require 24-Hour Response", {"_id": 79435, "_name": "Dai Jialing" }, {"name": "October 1, 2007", "start": 1191168000, "end": 1191254399 }, "Under a stringent new recall system being considered by Chinese authorities, pharmaceutical firms would need to initiate the recall of any product deemed harmful to health within 24 hours.", "http://www.pharmasianews.com/2007/10/china-drug-reca.html", 743]},
{"_name": "Sanofi-Aventis To Work With Chinese Experts In Cancer Stem-Cell Research", "_id": 116072, "_link": "http://tromblyltd.dabbledb.com/dabble/reports?view=793332&entry=116072",  "values": ["Sanofi-Aventis To Work With Chinese Experts In Cancer Stem-Cell Research", {"_id": 79435, "_name": "Dai Jialing" }, {"name": "September 24, 2007", "start": 1190563200, "end": 1190649599 }, "Sanofi-Aventis will expand its footprint in China by collaborating with Tianjin’s Institute of Hematology and Blood Diseases Hospital (IHBDH) in the field of cancer stem cells, the French drug maker announced Sept. 14.", "http://www.pharmasianews.com/2007/09/sanofi-aventis-.html", 533]},
{"_name": "Contract Manufacturer Sigma-Aldrich Looks Toward China To Lower Costs", "_id": 117373, "_link": "http://tromblyltd.dabbledb.com/dabble/reports?view=793332&entry=117373",  "values": ["Contract Manufacturer Sigma-Aldrich Looks Toward China To Lower Costs", {"_id": 497687, "_name": "Ying Huang" }, {"name": "September 24, 2007", "start": 1190563200, "end": 1190649599 }, "Sigma-Aldrich will expand its contract manufacturing business into China with a $25 million investment in a new Asia-Pacific manufacturing hub in Wuxi New District Park (WND), the St. Louis-based manufacturer announced Sept. 12.", "http://www.pharmasianews.com/2007/09/contract-manufa.html", 626]},
{"_name": "USP Opens New Facility In Shanghai", "_id": 94190, "_link": "http://tromblyltd.dabbledb.com/dabble/reports?view=793332&entry=94190",  "values": ["USP Opens New Facility In Shanghai", {"_id": 79435, "_name": "Dai Jialing" }, {"name": "September 17, 2007", "start": 1189958400, "end": 1190044799 }, "U.S. Pharmacopeia opened a new international facility in Shanghai’s Zhangjiang Hi-Tech Park Sept. 8 to work with Chinese companies and regulators on meeting international standards and ensuring the safety of pharmaceuticals, dietary supplements and ingredients.", "http://www.pharmasianews.com/2007/09/usp-opens-new-f.html", 554]},
{"_name": "AstraZeneca Opens Clinical Research Facility In China", "_id": 94488, "_link": "http://tromblyltd.dabbledb.com/dabble/reports?view=793332&entry=94488",  "values": ["AstraZeneca Opens Clinical Research Facility In China", {"_id": 497687, "_name": "Ying Huang" }, {"name": "September 17, 2007", "start": 1189958400, "end": 1190044799 }, "AstraZeneca opened its first Chinese Clinical Pharmacology Unit (CPU) Sept. 4, partnering with Peking University on a facility that will focus on Phase I research of therapies targeting infections, diabetes and cardiovascular diseases. ", "http://www.pharmasianews.com/2007/09/astrazeneca-ope.html", 620]},
{"_name": "China intensfies the export food safety", "_id": 97838, "_link": "http://tromblyltd.dabbledb.com/dabble/reports?view=793332&entry=97838",  "values": ["China intensfies the export food safety", {"_id": 79435, "_name": "Dai Jialing" }, {"name": "September 17, 2007", "start": 1189958400, "end": 1190044799 }, "China has prohibited 35 categories of food products, including dietary supplements, from leaving the country unless they have quality inspection labels, as of Sept. 1.", "http://www.pharmasianews.com/2007/09/us-should-ban-i.html", 747]},
{"_name": "First Chinese Research Center For Food-Drug Safety Will Increase Transparency Of Regulatory Decisions", "_id": 88040, "_link": "http://tromblyltd.dabbledb.com/dabble/reports?view=793332&entry=88040",  "values": ["First Chinese Research Center For Food-Drug Safety Will Increase Transparency Of Regulatory Decisions", {"_id": 79435, "_name": "Dai Jialing" }, {"name": "September 10, 2007", "start": 1189353600, "end": 1189439999 }, "Shanghai’s Safety Research Center for Food and Drugs officially opened Aug. 28, with a mission to improve communication between the government and industry by providing guidelines on the direction of government policies and making the process of policymaking more transparent.", "http://www.pharmasianews.com/2007/09/first-chinese-r.html", 788]},
{"_name": "China Announces Drug Ad Restrictions; 4-Month Safety Campaign", "_id": 88089, "_link": "http://tromblyltd.dabbledb.com/dabble/reports?view=793332&entry=88089",  "values": ["China Announces Drug Ad Restrictions; 4-Month Safety Campaign", {"_id": 497687, "_name": "Ying Huang" }, {"name": "September 9, 2007", "start": 1189267200, "end": 1189353599 }, "China’s Vice-Premier Wu Yi announced the start of a four-month campaign – the National Product Quality and Food Safety Special Rectification Action Program – to reduce unsafe pharmaceuticals and other products during an Aug. 27 nationally televised press conference held by the State Council in Beijing.", "http://www.pharmasianews.com/2007/09/china-announces.html", 751]},
{"_name": "AstraZeneca Adopts Digital Security To Deter Chinese Counterfeiting", "_id": 87463, "_link": "http://tromblyltd.dabbledb.com/dabble/reports?view=793332&entry=87463",  "values": ["AstraZeneca Adopts Digital Security To Deter Chinese Counterfeiting", {"_id": 497687, "_name": "Ying Huang" }, {"name": "September 5, 2007", "start": 1188921600, "end": 1189007999 }, "AstraZeneca China has added digital security to its packaging for four products in an effort to deter counterfeiting and improve security, the company announced Aug. 14. ", "http://www.pharmasianews.com/2007/09/astrazeneca-ado.html", 910]},
{"_name": "China Forbids Leasing Of Drug Store Shelves", "_id": 86274, "_link": "http://tromblyltd.dabbledb.com/dabble/reports?view=793332&entry=86274",  "values": ["China Forbids Leasing Of Drug Store Shelves", {"_id": 79435, "_name": "Dai Jialing" }, {"name": "August 27, 2007", "start": 1188144000, "end": 1188230399 }, "Chinese drug stores are no longer allowed to rent shelf space to drug suppliers, previously a common marketing practice, or to put OTC and prescription drug products and non-drug products next to each other on store shelves. Sale of prescription drugs off the open shelf is also prohibited under a rule issued Aug. 13 by the State Food and Drug Administration.", "http://www.pharmasianews.com/2007/08/china-forbids-l.html", 484]},
{"_name": "Trade Secret Status Triggers Marketing Exclusivity For Chinese Drug Manufacturer", "_id": 86348, "_link": "http://tromblyltd.dabbledb.com/dabble/reports?view=793332&entry=86348",  "values": ["Trade Secret Status Triggers Marketing Exclusivity For Chinese Drug Manufacturer", {"_id": 497687, "_name": "Ying Huang" }, {"name": "August 27, 2007", "start": 1188144000, "end": 1188230399 }, "A traditional medicine used to treat osteoporosis has been declared a technological secret by the Chinese government, providing the Tongjitang Chinese Medicine Company with five years of marketing exclusivity under State Food and Drug Administration rules.", "http://www.pharmasianews.com/2007/08/trade-secret-st.html", 847]},
{"_name": "SFDA Sticks To Familiar Theme During Second Press Conference: Food And Drug", "_id": 84625, "_link": "http://tromblyltd.dabbledb.com/dabble/reports?view=793332&entry=84625",  "values": ["SFDA Sticks To Familiar Theme During Second Press Conference: Food And Drug", {"_id": 79435, "_name": "Dai Jialing" }, {"name": "August 20, 2007", "start": 1187539200, "end": 1187625599 }, "China’s State Food and Drug Administration stuck to a familiar theme during its second monthly press conference in Beijing Aug. 8, outlining several measures intended to improve food and drug safety.", "http://www.pharmasianews.com/2007/08/sfda-sticks-to-.html", 686]},
{"_name": "China Announces Stricter Regulations For Medical Devices", "_id": 84647, "_link": "http://tromblyltd.dabbledb.com/dabble/reports?view=793332&entry=84647",  "values": ["China Announces Stricter Regulations For Medical Devices", {"_id": 497687, "_name": "Ying Huang" }, {"name": "August 20, 2007", "start": 1187539200, "end": 1187625599 }, "China’s State Food and Drug Administration acknowledged during its second monthly press conference Aug. 8 that imperfections in some laws and regulations have contributed to medical device safety problems. ", "http://www.pharmasianews.com/2007/08/china-announces.html", 908]},
{"_name": "U.S. Delegation Visits China To Jump Start Development Of Safety MOAs", "_id": 83945, "_link": "http://tromblyltd.dabbledb.com/dabble/reports?view=793332&entry=83945",  "values": ["U.S. Delegation Visits China To Jump Start Development Of Safety MOAs", {"_id": 79435, "_name": "Dai Jialing" }, {"name": "August 13, 2007", "start": 1186934400, "end": 1187020799 }, "A delegation of U.S. officials from FDA and the Department of Health and Human Services met with Chinese counterparts in Beijing earlier this month to establish a framework for drafting two Memoranda of Agreement related to drug and medical device safety, and food and feed safety.", "http://www.pharmasianews.com/2007/08/us-delegation-v.html", 688]},
{"_name": "GSK Signs Copromotion Deal With Chinese Manufacturer For Influenza Vaccine", "_id": 83993, "_link": "http://tromblyltd.dabbledb.com/dabble/reports?view=793332&entry=83993",  "values": ["GSK Signs Copromotion Deal With Chinese Manufacturer For Influenza Vaccine", {"_id": 497687, "_name": "Ying Huang" }, {"name": "August 13, 2007", "start": 1186934400, "end": 1187020799 }, "Chinese vaccine manufacturer Sinovac Biotech will copromote its influenza vaccine Anflu with GlaxoSmithKline (China) Investment Co. under an exclusive service agreement announced Aug. 1.", "http://www.pharmasianews.com/2007/08/gsk-signs-copro.html", 557]},
{"_name": "China Cracks Down On Counterfeit Drugs Under Shanying II Initiative", "_id": 83219, "_link": "http://tromblyltd.dabbledb.com/dabble/reports?view=793332&entry=83219",  "values": ["China Cracks Down On Counterfeit Drugs Under Shanying II Initiative", {"_id": 497687, "_name": "Ying Huang" }, {"name": "August 7, 2007", "start": 1186416000, "end": 1186502399 }, "China is attempting to crack down on intellectual property rights violations through a two-pronged approach focusing on enforcement actions and preventive measures.  ", "http://www.pharmasianews.com/2007/08/china-cracks-do.html", 586]},
{"_name": "China Expands Medical Insurance To Urban Residents Under New Pilot Program", "_id": 83322, "_link": "http://tromblyltd.dabbledb.com/dabble/reports?view=793332&entry=83322",  "values": ["China Expands Medical Insurance To Urban Residents Under New Pilot Program", {"_id": 79435, "_name": "Dai Jialing" }, {"name": "August 7, 2007", "start": 1186416000, "end": 1186502399 }, "The State Council of China has issued guidelines to set up a new pilot program to provide basic medical insurance to all urban residents. Announced July 10, the program will come into effect in September and cover 79 cities from different provinces, excluding Beijing, Shanghai, Tianjin and Chongqing.", "http://www.pharmasianews.com/2007/08/china-expands-m.html", 678]},
{"_name": "Chinese Province Implements Pilot Quality System To Strengthen Drug Safety", "_id": 82573, "_link": "http://tromblyltd.dabbledb.com/dabble/reports?view=793332&entry=82573",  "values": ["Chinese Province Implements Pilot Quality System To Strengthen Drug Safety", {"_id": 79435, "_name": "Dai Jialing" }, {"name": "July 30, 2007", "start": 1185724800, "end": 1185811199 }, "In the latest effort to strengthen drug safety measures in China, Guangdong province has taken a page out of the international quality systems playbook, launching a pilot system July 20 that assigns responsibility for drug manufacturing quality to a designated company official.", "http://www.pharmasianews.com/2007/07/chinese-provinc.html", 685]},
{"_name": "Guangdong’s Online Bidding System Drives Down Drug Prices", "_id": 82611, "_link": "http://tromblyltd.dabbledb.com/dabble/reports?view=793332&entry=82611",  "values": ["Guangdong’s Online Bidding System Drives Down Drug Prices", {"_id": 497687, "_name": "Ying Huang" }, {"name": "July 30, 2007", "start": 1185724800, "end": 1185811199 }, "Public medical institutions in China’s Guangdong province will look to lower drug prices by purchasing pharmaceuticals directly from manufacturers via a new online bidding system set to launch in August, according to government officials.", "http://www.pharmasianews.com/2007/07/guangdongs-onli.html", 734]},
{"_name": "New Registration Provisions Will Strengthen Chinese Oversight Of Pharma Industry", "_id": 81850, "_link": "http://tromblyltd.dabbledb.com/dabble/reports?view=793332&entry=81850",  "values": ["New Registration Provisions Will Strengthen Chinese Oversight Of Pharma Industry", {"_id": 79435, "_name": "Dai Jialing" }, {"name": "July 23, 2007", "start": 1185120000, "end": 1185206399 }, "China’s State Food and Drug Administration revised its drug registration provisions July 12, improving supervision and tightening approval standards in the wake of widespread concern related to drug safety.", "http://fdcalerts.typepad.com/asia/2007/07/new-registratio.html", 698]},
{"_name": "Bulk Drug Prices Expected To Rise As China Cuts Export Incentives", "_id": 82268, "_link": "http://tromblyltd.dabbledb.com/dabble/reports?view=793332&entry=82268",  "values": ["Bulk Drug Prices Expected To Rise As China Cuts Export Incentives", {"_id": 497687, "_name": "Ying Huang" }, {"name": "July 23, 2007", "start": 1185120000, "end": 1185206399 }, "China is set to cut export incentives on close to 3,000 different products, including polluting industries such as bulk pharmaceuticals, beginning this month.", "http://fdcalerts.typepad.com/asia/2007/07/bulk-drug-price.html", 748]},
{"_name": "Shanghai Set To Blacklist Corrupt Pharmaceutical Firms", "_id": 81016, "_link": "http://tromblyltd.dabbledb.com/dabble/reports?view=793332&entry=81016",  "values": ["Shanghai Set To Blacklist Corrupt Pharmaceutical Firms", {"_id": 79435, "_name": "Dai Jialing" }, {"name": "July 17, 2007", "start": 1184601600, "end": 1184687999 }, "Shanghai’s Ministry of Heath enacted new regulations July 3 that will blacklist any company found to have given bribes to a hospital or medical institution. ", "http://fdcalerts.typepad.com/asia/2007/07/shanghai-set-to.html", 602]},
{"_name": "China Acknowledges Drug Safety Problems; Promises More Supervision", "_id": 81213, "_link": "http://tromblyltd.dabbledb.com/dabble/reports?view=793332&entry=81213",  "values": ["China Acknowledges Drug Safety Problems; Promises More Supervision", {"_id": 497687, "_name": "Ying Huang" }, {"name": "July 17, 2007", "start": 1184601600, "end": 1184687999 }, "China’s drug watchdog admitted that the country's food and drug safety situation was unsatisfactory and that supervision needed to be strengthened at an inaugural press conference sponsored by the State Council Information Office in Beijing on July 10. ", "http://fdcalerts.typepad.com/asia/2007/07/china-acknowled.html", 724]},
{"_name": "Chinese Pharma Company Launches Generics Of Lilly's Zyprexa", "_id": 80246, "_link": "http://tromblyltd.dabbledb.com/dabble/reports?view=793332&entry=80246",  "values": ["Chinese Pharma Company Launches Generics Of Lilly's Zyprexa", {"_id": 79435, "_name": "Dai Jialing" }, {"name": "July 9, 2007", "start": 1183910400, "end": 1183996799 }, "Hansenpharm Co. began selling generic versions of Lilly's blockbuster antipsychotic Zyprexa (olanzapine) in China this month after winning a groundbreaking lawsuit against Lilly late last year. ", "http://fdcalerts.typepad.com/asia/2007/07/chinese-pharma-.html", 540]},
{"_name": "Beijing Bans Ten Illegally Advertised Drugs, Requires Apologies From Makers", "_id": 80247, "_link": "http://tromblyltd.dabbledb.com/dabble/reports?view=793332&entry=80247",  "values": ["Beijing Bans Ten Illegally Advertised Drugs, Requires Apologies From Makers", {"_id": 497687, "_name": "Ying Huang" }, {"name": "July 9, 2007", "start": 1183910400, "end": 1183996799 }, "The Beijing Drug Administration banned ten drugs for illegal advertising June 28, marking the first time Chinese authorities have implemented their enhanced enforcement authority under drug advertising regulations enacted earlier this year.", "http://fdcalerts.typepad.com/asia/2007/07/beijing-bans-te.html", 630]},
{"_name": "Traditional Chinese Medicine Goes Global", "_id": 79418, "_link": "http://tromblyltd.dabbledb.com/dabble/reports?view=793332&entry=79418",  "values": ["Traditional Chinese Medicine Goes Global", {"_id": 497687, "_name": "Ying Huang" }, {"name": "July 2, 2007", "start": 1183305600, "end": 1183391999 }, "Traditional Chinese Medicine Goes Global\r\nChina’s traditional medicine manufacturers have begun looking toward foreign markets for their products. This past week, an anti-dementia drug called NJS became the first such product to be patented by a foreign firm.", "http://fdcalerts.typepad.com/asia/2007/07/traditional-chi.html#more", 400]},
{"_name": "China To Set Up National Surveillance Network For Controlled Substances", "_id": 79456, "_link": "http://tromblyltd.dabbledb.com/dabble/reports?view=793332&entry=79456",  "values": ["China To Set Up National Surveillance Network For Controlled Substances", {"_id": 497687, "_name": "Ying Huang" }, {"name": "July 2, 2007", "start": 1183305600, "end": 1183391999 }, "The State Food and Drug Administration announced last week that China will set up a national surveillance network to monitor the production, distribution and use of narcotic and psychotropic drugs.", "http://fdcalerts.typepad.com/asia/2007/07/china-to-set-up.html#more", 644]},
{"_name": "Drug Safety Concerns Spark SFDA Inspections Of Chinese Manufacturers", "_id": 79124, "_link": "http://tromblyltd.dabbledb.com/dabble/reports?view=793332&entry=79124",  "values": ["Drug Safety Concerns Spark SFDA Inspections Of Chinese Manufacturers", {"_id": 72736, "_name": "Rachel Liu" }, {"name": "June 18, 2007", "start": 1182096000, "end": 1182182399 }, "China ramped up inspections of its pharmaceutical industry during the first half of June in response to heightened concerns over drug safety, according to State Food and Drug Administration reports.", "http://fdcalerts.typepad.com/asia/2007/06/drug_safety_con.html#more", 500]},
{"_name": "China SFDA Seeks Public Comment On Change To Proposed Definition Of 'New' Drugs", "_id": 79097, "_link": "http://tromblyltd.dabbledb.com/dabble/reports?view=793332&entry=79097",  "values": ["China SFDA Seeks Public Comment On Change To Proposed Definition Of 'New' Drugs", {"_id": 72736, "_name": "Rachel Liu" }, {"name": "June 11, 2007", "start": 1181491200, "end": 1181577599 }, "Chinese regulators are soliciting a second round of public comment on proposed changes to China's drug registration rules that would narrow the criteria under which a drug could be considered \"new.\"", "http://fdcalerts.typepad.com/asia/2007/06/china_sfda_seek.html#more", 526]},
{"_name": "SFDA Simplifies Process For Modifying Medical Device Registration", "_id": 567831, "_link": "http://tromblyltd.dabbledb.com/dabble/reports?view=793332&entry=567831",  "values": ["SFDA Simplifies Process For Modifying Medical Device Registration", {"_id": 79435, "_name": "Dai Jialing" }, {"name": "January 11, 2007", "start": 1168444800, "end": 1168531199 }, "China's State FDA released Jan. 3 requirements for device applicants to modify registration certificates as a step to simplify registration of devices. ", "http://www.pharmasianews.com/fdcreports/story/viewStory.do?targetGUID={7B02BD17-CAE2-4F54-A2D5-511193CC4C03}", 382]},
{"_name": "Sirnaomics' siRNA Therapeutic To Begin Clinical Trials In China", "_id": 536127, "_link": "http://tromblyltd.dabbledb.com/dabble/reports?view=793332&entry=536127",  "values": ["Sirnaomics' siRNA Therapeutic To Begin Clinical Trials In China", {"_id": 79435, "_name": "Dai Jialing" }, {"name": "January 9, 2007", "start": 1168272000, "end": 1168358399 }, "Sirnaomics' RNAi therapeutic STP601 will begin clinical trials in China in late 2008, Patrick Lu, founder, president and CEO of Sirnaomics, told PharmAsia News. ", "http://www.pharmasianews.com/fdcreports/story/viewStory.do?targetGUID={B1CC268E-91D4-4B1E-A9B2-015997A0F8F4}&AuthToken=-658542581", 484]}]});